Get the Daily Brief
Latest Biotech News
Revolutionizing Oncology: New Therapeutics and Diagnostic Innovations
Progress in cancer research reveals promising therapeutic and diagnostic breakthroughs. Advancements in antibody-drug conjugates (ADCs) demonstrate enhanced selectivity and clinical potential...
Breakthroughs in Pancreatic Cancer Research Illuminate Biomarkers and Therapeutic Targets
New insights into pancreatic cancer uncover critical molecular and microbial factors influencing disease progression. Salk Institute and University of California San Diego researchers identified...
Innovations in Biomanufacturing Drive Greater Efficiency and Downstream Development
Process intensification and advanced analytics are transforming biologics manufacturing. Lonza and Sartorius collaboration highlights Raman spectroscopy as an inline process analytical technology...
Pediatric and Neonatal Care Highlighted by Vaccine Development and Clinical Innovations
Significant strides are being made in pediatric health with initiatives targeting HIV vaccination and neonatal care. A multi-institutional team led by Weill Cornell Medicine secured a $20.8...
Advances in Plant Biology and Sustainable Agricultural Technologies
Recent studies have unveiled key plant mechanisms and innovative approaches to sustainable agriculture. Suga et al. identified barley protein HvAACT1 critical for tolerance to acidic,...
Roche Accelerates MASH Drug Development With $3.5B 89bio Acquisition
Roche has taken a significant step into metabolic dysfunction-associated steatohepatitis (MASH) treatment by agreeing to acquire 89bio for up to $3.5 billion. The deal centers on 89bio's phase III...
CRISPR and Prime Editing Technologies Advance Gene Therapy Precision
Researchers at MIT and UC San Diego have reported pivotal enhancements in gene editing precision. MIT scientists engineered prime editors with significantly reduced error rates, mitigating...
AI Models Break New Ground in Disease Risk Prediction and Genome Design
Artificial intelligence continues to push boundaries in biotechnology. An AI model trained on UK Biobank data can predict the risk and timing of over 1,000 diseases up to 20 years in advance,...
CDC’s Advisory Committee Faces Turmoil Amid Vaccine Schedule Controversies
The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has encountered turmoil amid votes and discussions on vaccinating newborns against...
Endpoints 11 Highlights Next-Generation Biotechnology Innovators
Endpoints News unveiled its 2025 Endpoints 11 winners spotlighting leading-edge biotech startups transforming drug discovery and therapies. Companies like Chai Discovery are harnessing AI for...
Advances in Cancer Detection, Immunotherapy, and Drug Delivery Systems
The oncology field marks notable advances: NucleoBio and PreCheck Health Services collaborate on a novel prostate cancer test using qPCR and machine learning to detect RNA biomarkers in men of...
Lung and Neonatal Health: From Cancer Mechanisms to Imaging Innovations
Recent breakthroughs target small cell lung cancer origins through basal stem-like cells as revealed by Duke University, overturning previous assumptions about neuroendocrine cell origins. Novel...
Cutting-Edge Diagnostics and Therapeutics in Infectious Diseases
Researchers have made notable strides in infectious disease diagnostics and therapy. Tulane University and Shenzhen Third People’s Hospital developed ActCRISPR-TB, an improved CRISPR-based...
Bioprocess Intensification and Analytical Technology Innovations
Efforts to optimize biomanufacturing have advanced with process intensification strategies integrating continuous production and advanced analytics. Lonza Biologics’ Courtney Hazelton-Harrington...
Roche's $3.5B 89bio Buyout Targets Liver Disease MASH
Swiss pharma giant Roche has acquired 89bio for $2.4 billion upfront, with potential milestones taking the total to $3.5 billion, acquiring the late-stage drug pegozafermin for metabolic...
CRISPR-based Advances for Neurodevelopmental and Infectious Diseases
Researchers at UCSF have demonstrated CRISPR activation to boost expression of the functional SCN2A gene in mice, restoring synapse function and improving neurodevelopmental outcomes relevant for...
Oral Microbiome Links to Pancreatic Cancer Risk
A comprehensive cohort study led by NYU Langone Health and Perlmutter Cancer Center has identified specific oral bacterial and fungal species, including Candida yeast and periodontal pathogens,...
AI Models Forecast Disease Risk Across Thousands of Conditions
Scientists have developed an advanced generative AI model trained on UK Biobank data capable of simultaneously predicting an individual's risk and timing of developing over 1,000 diseases up to 20...
Biotech Workforce Realignments Amid Market Pressures
Cell therapy startups Arsenal Biosciences and X4 Pharmaceuticals announced significant layoffs, cutting their workforces by half amid ongoing restructuring. Arsenal Bio pivoted towards...
Regulatory Turmoil at CDC Impacts Vaccine Policies
The firing of CDC Director Susan Monarez by Health Secretary Robert F. Kennedy Jr. has sparked alarm over federal vaccine policy changes. Monarez testified that Kennedy pressured her to approve...